Skip to main content

Table 1 Correlations between SATB1 expression, clinicopathologic features and MGMT promoter methylation in 70 cases of glioma

From: Upregulation of SATB1 is associated with the development and progression of glioma

Clinicopathologic variables n SATB1 expression X 2 P-value
   Negative Positive   
All cases 70 26 44   
Age (years)     1.004 0.446
<45 27 12 15   
45 43 14 29   
Gender     0.388 0.566
Male 54 19 35   
Female 16 7 9   
Tumor size (cm)     0.227 0.795
<3 24 8 16   
3 46 18 28   
Tumor locus     0.946 0.393
Supratentorial 53 18 35   
Infratentorial 17 8 9   
Pathological grade     6.119 0.025
Low grade I-II 35 18 17   
High grade III-IV 35 8 27   
MGMT promoter     25.150 0.000
Unmethylation 45 7 38   
Methylation 25 19 6